Core Diagnostics, Inc., located in Hayward, California, is a venture capital-backed full-services esoteric pathology laboratory with molecular diagnostic capabilities in oncology.

Our CLIA certified laboratory conducts screenings of clinical samples for assays developed internally (e.g. LDTs) or available commercially (e.g. IVDs). Our molecular testing expertise encompasses FISH assays, mutational and gene expression analysis (low- and high-throughput PCR), histology, and IHC assays for clinical research and diagnosis. We also provide biomarker services, ranging from early research studies to analyses of Phase III clinical trial samples, to our Biotech and BioPharma clients. We work seamlessly as an extension of our clients’ teams to develop strategies and assays as per their requirements.

Our unique capabilities include access to a sub-specialty expert panel of pathologists and a web-based digital pathology platform for data reporting, case management, and integrated diagnostics.

Core Diagnostics is superbly positioned as a premier provider of molecular diagnostic services with state-of-the-art laboratory facilities, an experienced management team, and partnerships with cell enrichment technology vendors. Our clinical laboratory and leadership team has experts in FISH assays, hematologic cancers, healthcare, and information technology.